Credence Research Logo

Home » Medical Devices » Cardiac Rehabilitation Market

Cardiac Rehabilitation Market By Product Type (Treadmill, Elliptical Trainer, Stabilization Ball, Rower, Blood Pressure Monitor, Heart Rate Monitor, Others); By Indication (Coronary Artery Disease, Myocardial Infarction, Coronary Artery Bypass Grafting, Percutaneous Coronary Intervention, Others); By End User (Rehabilitation Centers, Hospitals and Clinics, Homecare, Others) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Report ID: 35105 | Report Format : Excel, PDF

Market Overview:

The Cardiac Rehabilitation market size was valued at USD 1,526.11 million in 2018, increased to USD 2,292.87 million in 2024, and is anticipated to reach USD 3,924.20 million by 2032, at a CAGR of 6.47% during the forecast period.

REPORT ATTRIBUTE DETAILS
Historical Period 2020-2023
Base Year 2024
Forecast Period 2025-2032
Cardiac Rehabilitation Market Size 2024 USD 2,292.87 million
Cardiac Rehabilitation Market, CAGR 6.47%
Cardiac Rehabilitation Market Size 2032 USD 3,924.20 million

 

The cardiac rehabilitation market is led by prominent players such as Philips Healthcare, Medtronic PLC, GE Healthcare, LivaNova PLC, Baxter International Inc., and BioTelemetry, Inc., all of which offer advanced cardiac monitoring systems, rehabilitation equipment, and integrated care solutions. These companies maintain their competitive edge through innovation, strategic collaborations, and global reach. North America emerged as the leading region in 2024, capturing 42.3% of the global market share, driven by high healthcare expenditure, favorable reimbursement policies, and widespread adoption of technologically advanced rehabilitation programs. Asia Pacific, with a rapidly growing patient base and rising healthcare investments, represents the fastest-growing regional market.

Cardiac Rehabilitation Market size

Market Insights

  • The cardiac rehabilitation market was valued at USD 2,292.87 million in 2024 and is projected to reach USD 3,924.20 million by 2032, growing at a CAGR of 6.47% during the forecast period.
  • The market is primarily driven by the rising prevalence of cardiovascular diseases, aging populations, and growing awareness about the benefits of cardiac rehabilitation in preventing recurrent cardiac events.
  • Technological advancements such as tele-rehabilitation and wearable health monitoring devices are trending, enabling home-based and hybrid cardiac care solutions to gain traction globally.
  • Leading players like Philips Healthcare, Medtronic, and GE Healthcare dominate the market through strategic partnerships, diversified portfolios, and geographic expansion; treadmill remains the dominant product type, while hospitals and clinics are the key end users.
  • Regionally, North America leads with a 42.3% share, followed by Europe (28.2%) and Asia Pacific (20.2%); however, limited infrastructure in low-income regions and low patient adherence rates pose ongoing restraints.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Market Segmentation Analysis:

By Product Type

The Treadmill segment held the largest share in the cardiac rehabilitation market by product type, accounting for a significant portion of the revenue in 2024. Treadmills are widely used in rehabilitation programs due to their effectiveness in controlled cardiovascular training, ease of monitoring patient progress, and adaptability to various fitness levels. The increasing adoption of technologically advanced treadmills with real-time heart rate monitoring and connectivity features is further driving segment growth. Rising awareness about physical activity in cardiac recovery and the incorporation of treadmills in both clinical and home-based settings contribute to their dominant market share.

  • For instance, Life Fitness introduced the Integrity+ Cardio series in 2023, featuring a 24-inch console and Wi-Fi/Bluetooth integration that connects with over 50 third-party rehab and fitness apps used in over 2,000 rehabilitation facilities worldwide.

By Indication

Coronary Artery Disease (CAD) emerged as the leading indication segment, capturing the highest revenue share in 2024. The high prevalence of CAD globally, combined with its role as a primary cause of cardiovascular morbidity, has resulted in its dominance. The increasing number of lifestyle-related risk factors, such as obesity, diabetes, and smoking, continues to fuel demand for structured rehabilitation programs. Cardiac rehab for CAD patients improves cardiovascular function and reduces hospital readmissions, which makes it a key therapeutic focus. Supportive guidelines and reimbursement policies for CAD rehabilitation further boost segment expansion.

  • For instance, Cleveland Clinic reported that out of 3,128 CAD patients enrolled in its cardiac rehab program in 2022, 1,972 completed all 36 prescribed sessions, resulting in a 22% reduction in readmission rates within six months.

By End User

Hospitals and Clinics represented the largest end-user segment in 2024, driven by their integrated care infrastructure, skilled personnel, and advanced diagnostic capabilities. These facilities offer comprehensive cardiac rehabilitation programs that encompass physical therapy, nutritional counseling, and psychological support. The segment benefits from the growing number of cardiovascular procedures and hospitalizations, necessitating post-discharge rehabilitation. Additionally, government initiatives and insurance coverage for in-hospital rehab services have bolstered demand. While homecare is gaining traction due to convenience and tele-rehab technologies, hospitals remain the primary choice for supervised and intensive cardiac recovery programs.

Market Overview

Rising Prevalence of Cardiovascular Diseases (CVDs)

The increasing incidence of cardiovascular diseases such as coronary artery disease, myocardial infarction, and heart failure is a primary driver for the cardiac rehabilitation market. As sedentary lifestyles, obesity, smoking, and diabetes continue to rise globally, the demand for structured rehabilitation programs has surged. Cardiac rehabilitation has proven effective in reducing mortality rates, improving quality of life, and preventing disease recurrence. This growing burden of CVDs is pushing healthcare providers and policymakers to emphasize secondary prevention, thus driving widespread adoption of cardiac rehab programs across healthcare settings.

  • For instance, the American Heart Association partnered with Apple in 2021 to track cardiovascular health using Apple Watch, resulting in over 60,000 users actively participating in fitness and recovery challenges tied to cardiac health across 40 U.S. states.

Favorable Reimbursement Policies and Government Initiatives

Supportive reimbursement frameworks, particularly in developed regions like North America and Europe, are significantly boosting market growth. Public health authorities and insurance providers increasingly recognize the cost-effectiveness of cardiac rehabilitation in reducing long-term hospital readmissions and enhancing patient recovery. Government-funded programs and mandates promoting preventive healthcare have led to expanded access to rehab services. These financial incentives not only encourage patients to enroll in rehabilitation programs but also motivate healthcare providers to offer integrated cardiac care, contributing to consistent market expansion.

  • For instance, in 2023, the U.S. Centers for Medicare & Medicaid Services (CMS) reimbursed up to 72 rehabilitation sessions per patient under its Comprehensive Cardiac Rehabilitation program, covering over 1.4 million eligible beneficiaries across the country.

Advancements in Tele-rehabilitation and Remote Monitoring Technologies

The integration of digital health technologies, such as tele-rehabilitation platforms and wearable health monitors, has revolutionized the cardiac rehabilitation landscape. These innovations enable remote patient monitoring, virtual consultations, and personalized therapy plans, making cardiac rehab more accessible, especially in rural or underserved regions. Post-pandemic demand for home-based care has accelerated the adoption of these tools, allowing patients to participate in structured programs without visiting healthcare facilities. This technological evolution enhances patient engagement, compliance, and clinical outcomes, thereby fueling growth in the global cardiac rehabilitation market.

Cardiac Rehabilitation Market share

Key Trends & Opportunities

Shift Toward Home-based and Hybrid Rehabilitation Models

A notable trend in the cardiac rehabilitation market is the transition from traditional, facility-based models to home-based and hybrid approaches. Driven by patient preference for convenience, reduced mobility in elderly populations, and the impact of COVID-19, healthcare systems are investing in hybrid programs that combine virtual and in-person care. This shift offers opportunities for technology providers, app developers, and wearable device manufacturers to collaborate with healthcare institutions. The trend supports broader access to rehab services and aligns with value-based care models aimed at long-term patient wellness.

  • For instance, Kaiser Permanente launched a home-based cardiac rehab model in 2021 that enrolled over 3,400 patients across California, achieving a completion rate of 77% compared to 54% in traditional clinic-based programs.

Expansion into Emerging Markets

Emerging economies in Asia-Pacific, Latin America, and the Middle East present significant growth opportunities due to the rising burden of CVDs and improving healthcare infrastructure. Increasing public health awareness, urbanization, and economic development are pushing governments to invest in preventive healthcare and chronic disease management. Multinational healthcare providers and medical device companies are eyeing these regions for strategic expansion. As affordability improves and digital health technologies penetrate new markets, the cardiac rehabilitation sector stands to benefit from higher patient volumes and diversified revenue streams.

  • For instance, Medtronic established its first regional cardiac care center in Hyderabad, India, in 2022, training over 500 cardiologists and deploying 1,200 remote patient monitoring devices in its first year to support cardiac rehab accessibility.

Key Challenges

Limited Access in Low- and Middle-Income Countries

Despite its proven benefits, cardiac rehabilitation remains underutilized in many low- and middle-income countries due to inadequate infrastructure, limited awareness, and high out-of-pocket costs. Many healthcare systems in these regions prioritize acute care over long-term recovery programs, leading to poor implementation of rehabilitation services. Additionally, cultural stigmas and logistical barriers prevent widespread participation. This access gap not only limits market growth but also underscores the need for global initiatives to make cardiac rehab more affordable and scalable in resource-constrained settings.

Patient Adherence and Dropout Rates

Maintaining patient adherence throughout the rehabilitation process is a persistent challenge. Factors such as lack of motivation, time constraints, transportation difficulties, and insufficient family support often lead to high dropout rates. Even with home-based programs, sustaining engagement over the long term requires structured follow-ups and behavioral interventions. Healthcare providers struggle to personalize rehab plans at scale, which affects patient retention and the overall effectiveness of treatment. Improving adherence remains critical to maximizing outcomes and realizing the full market potential of cardiac rehabilitation services.

Regional Analysis

North America

North America held the largest share in the global cardiac rehabilitation market in 2024, accounting for approximately 42.3% of the total market, with a valuation of USD 969.69 million, up from USD 652.33 million in 2018. The region is projected to reach USD 1,664.31 million by 2032, registering a CAGR of 6.5% during the forecast period. The high adoption rate of advanced medical technologies, favorable reimbursement policies, and a well-established healthcare infrastructure contribute to North America’s dominance. Moreover, the rising prevalence of cardiovascular diseases and lifestyle-related health conditions continues to fuel the demand for cardiac rehabilitation services.

Europe

Europe accounted for approximately 28.2% of the global cardiac rehabilitation market in 2024, with a market size of USD 647.10 million, rising from USD 446.31 million in 2018. The market is expected to reach USD 1,044.71 million by 2032, growing at a CAGR of 5.7%. The growth is driven by increasing government focus on preventive healthcare, aging population, and improved access to rehabilitation services across countries such as Germany, the UK, and France. Europe’s healthcare systems support cardiac rehab integration into post-surgical recovery protocols, encouraging broader participation and investment in facility-based and hybrid rehabilitation models.

Asia Pacific

Asia Pacific is emerging as the fastest-growing region in the cardiac rehabilitation market, expanding at a CAGR of 8.2%. The market size increased from USD 284.37 million in 2018 to USD 464.25 million in 2024, and is projected to reach USD 903.02 million by 2032, capturing approximately 20.2% of the global market share in 2024. Rapid urbanization, growing prevalence of cardiovascular diseases, and increasing healthcare investments across China, India, and Southeast Asia are key growth drivers. Rising awareness of rehabilitation benefits and the expansion of tele-rehabilitation programs are also contributing to the region’s accelerated market expansion.

Latin America

Latin America held a modest share of around 4.6% of the global cardiac rehabilitation market in 2024, valued at USD 104.65 million, up from USD 70.55 million in 2018. The market is forecasted to reach USD 158.08 million by 2032, growing at a CAGR of 4.8%. Growth in this region is supported by the increasing incidence of non-communicable diseases, improvements in healthcare accessibility, and a rising middle-class population. Countries like Brazil and Mexico are making strides in integrating rehabilitation programs within public health systems. However, limited infrastructure and uneven access remain challenges for more widespread adoption.

Middle East

The Middle East accounted for 2.6% of the global cardiac rehabilitation market in 2024, with a market value of USD 59.71 million, up from USD 43.42 million in 2018. The region is expected to reach USD 86.50 million by 2032, registering a CAGR of 4.3%. Market growth is being driven by the rising burden of cardiovascular diseases, especially in Gulf countries, along with increasing healthcare investments and public-private partnerships. However, the availability of comprehensive rehabilitation services remains limited in several countries, and there is growing interest in home-based and digital rehab models to address accessibility gaps.

Africa

Africa represented the smallest share in the global cardiac rehabilitation market in 2024, accounting for about 2.1%, with a market value of USD 47.46 million, up from USD 29.12 million in 2018. The market is projected to reach USD 67.58 million by 2032, growing at a CAGR of 4.0%. The region faces challenges such as limited awareness, insufficient infrastructure, and a lack of specialized cardiac care centers. However, gradual improvements in healthcare access, increasing non-communicable disease burden, and support from international health organizations are expected to create opportunities for the expansion of cardiac rehabilitation services in the coming years.

Market Segmentations:

By Product Type

  • Treadmill
  • Elliptical Trainer
  • Stabilization Ball
  • Rower
  • Blood Pressure Monitor
  • Heart Rate Monitor
  • Others

By Indication

  • Coronary Artery Disease
  • Myocardial Infarction
  • Coronary Artery Bypass Grafting
  • Percutaneous Coronary Intervention
  • Others

By End User

  • Rehabilitation Centers
  • Hospitals and Clinics
  • Homecare
  • Others

By Geography

  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Spain
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • South-east Asia
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Argentina
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of the Middle East and Africa

Competitive Landscape

The cardiac rehabilitation market features a moderately competitive landscape, driven by innovation, strategic collaborations, and a strong focus on integrated healthcare solutions. Leading players such as Philips Healthcare, Medtronic PLC, GE Healthcare, and LivaNova PLC dominate through diverse product portfolios and global distribution networks. These companies invest heavily in research and development to introduce advanced monitoring systems, tele-rehabilitation platforms, and connected cardiovascular care technologies. Strategic mergers, acquisitions, and partnerships further strengthen their market positioning, enabling broader service offerings and entry into emerging markets. Mid-sized players like Cardiac Science Corporation, BioTelemetry, Inc., and Hill-Rom Holdings, Inc. contribute by offering specialized rehabilitation equipment and wearable devices. Market participants are increasingly focusing on home-based and hybrid rehabilitation models to cater to the growing demand for personalized and remote care. As the market evolves, the competition is expected to intensify, particularly with the entry of technology-driven startups and regional firms offering cost-effective solutions.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

  • Philips Healthcare
  • Medtronic, PLC
  • GE Healthcare
  • Cardiac Science Corporation
  • LivaNova PLC
  • Baxter International Inc.
  • Fujifilm Holdings Corporation
  • BioTelemetry, Inc.
  • Milwaukee Instruments, Inc.
  • Hill-Rom Holdings, Inc.

Recent Developments

  • In July 2025, Philips Healthcare announced a collaboration with Epic EHR to seamlessly integrate its cardiac ambulatory monitoring and diagnostics with Epic’s Aura platform, streamlining workflows and enhancing diagnostic and patient outcomes in cardiac care.
  • In June 2025, Philips healthcare partnered with Williamson Health (Tennessee) to expand access to advanced, community-based cardiac care using Philips technology for smart imaging, real-time data, and integrated digital workflows.
  • In June 2025, GE Healthcare Showcased the newly launched Flyrcado PET imaging tracer for myocardial perfusion (CAD diagnosis), now available across the U.S. with Medicare and commercial insurance coverage. Flyrcado enables improved diagnostic accuracy, especially with GE Healthcare’s Omni Legend PET/CT system, representing a new era for precise, personalized cardiac imaging.
  • In April 2025, Medtronic presented positive one-year outcomes for its Sphere-360 pulsed field ablation (PFA) catheter at the Heart Rhythm Society conference, demonstrating high efficacy and safety in treating atrial fibrillation. The data showed 88% of patients were free from arrhythmia recurrence and 98% achieved durable pulmonary vein isolation, with no reported serious adverse events. The Sphere-360 catheter is part of Medtronic’s FDA-approved PFA systems for atrial fibrillation.
  • In November 2024, Medtronic launched the ALERT study, a multicenter initiative in partnership with Tempus, to address disparities in valve disease care, particularly for underserved patient populations. The study uses artificial intelligence (AI) and integrated electronic health records (EHRs) to identify patients with severe aortic stenosis or moderate-to-severe mitral regurgitation who may be undertreated for these conditions, with a focus on evaluating treatments like TAVR (transcatheter aortic valve replacement.

Market Concentration & Characteristics

The Cardiac Rehabilitation Market exhibits a moderately concentrated structure with a mix of global leaders and regional players competing across product, service, and technology categories. It is characterized by steady growth, driven by the high burden of cardiovascular diseases, increasing clinical adoption of structured rehab programs, and expanding home-based care options. The market benefits from strong participation by established companies such as Philips Healthcare, Medtronic, GE Healthcare, and LivaNova PLC, which hold significant shares due to their wide-ranging portfolios and global presence. It features a high degree of innovation, particularly in digital health solutions and remote monitoring technologies that improve patient access and adherence. Most providers operate in an integrated care model, combining diagnostic tools, exercise equipment, and real-time patient tracking. It shows high barriers to entry in developed regions due to strict regulatory requirements and the need for technological expertise. Demand continues to grow in emerging markets where healthcare investments are rising steadily.

Report Coverage

The research report offers an in-depth analysis based on Product Type, Indication, End User and Geography. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

  1. The demand for cardiac rehabilitation services will continue to rise due to the increasing global burden of cardiovascular diseases.
  2. Home-based and hybrid rehabilitation models are expected to gain wider adoption, supported by digital health technologies.
  3. Tele-rehabilitation platforms and wearable monitoring devices will play a critical role in improving patient engagement and compliance.
  4. Emerging economies will present strong growth opportunities driven by improving healthcare infrastructure and rising awareness.
  5. Personalized rehabilitation plans tailored to individual patient needs will become more common across care settings.
  6. Collaborations between technology firms and healthcare providers will enhance service delivery and innovation.
  7. Regulatory support and favorable reimbursement policies will continue to expand access to cardiac rehab services.
  8. Artificial intelligence and data analytics will be increasingly integrated to optimize therapy outcomes and track patient progress.
  9. Equipment manufacturers will focus on portable, user-friendly devices to meet the growing demand for at-home care.
  10. Market competition will intensify as new entrants and startups introduce cost-effective and tech-enabled solutions.

CHAPTER NO. 1: GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2: EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3: CARDIAC REHABILITATION MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown

3.6 Price Trend Analysis

3.6.1 Regional Price Trend
3.6.2 Price Trend by Product

CHAPTER NO. 4: KEY INVESTMENT EPICENTER         

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Product Categories

4.3 Application Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Product Type & End User Revenue

CHAPTER NO. 6: TRADE & COMMERCE ANALYSIS     

6.1.      Import Analysis by Region

6.1.1.    Global Cardiac Rehabilitation Import Revenue By Region

6.2.      Export Analysis by Region

6.2.1.    Global Cardiac Rehabilitation Export Revenue By Region

CHAPTER NO. 7: COMPETITION ANALYSIS       

7.1.      Company Market Share Analysis

7.1.1.    Global Cardiac Rehabilitation: Company Market Share

7.2.      Global Cardiac Rehabilitation Company Revenue Market Share

7.3.      Strategic Developments

7.3.1.    Acquisitions & Mergers

7.3.2.    New Product Launch

7.3.3.    Regional Expansion

7.4.    Competitive Dashboard

7.5.    Company Assessment Metrics, 2024

CHAPTER NO. 8: CARDIAC REHABILITATION MARKET – BY PRODUCT TYPE SEGMENT ANALYSIS

8.1.      Cardiac Rehabilitation Overview by Product Type Segment

8.1.1.    Cardiac Rehabilitation Revenue Share By Product Type

8.2.      Treadmill

8.3.      Elliptical Trainer

8.4.      Stabilization Ball

8.5.      Rower

8.6.      Blood Pressure Monitor

8.7.      Heart Rate Monitor

8.8.      Others

CHAPTER NO. 9: CARDIAC REHABILITATION MARKET – BY INDICATION SEGMENT ANALYSIS

9.1.      Cardiac Rehabilitation Overview by Indication Segment

9.1.1.    Cardiac Rehabilitation Revenue Share By Indication

9.2.      Coronary Artery Disease

9.3.      Myocardial Infarction

9.4.      Coronary Artery Bypass Grafting

9.5.      Percutaneous Coronary Intervention

9.6.      Others

CHAPTER NO. 10: CARDIAC REHABILITATION MARKET – BY END USER SEGMENT ANALYSIS

10.1.     Cardiac Rehabilitation Overview by End User Segment

10.1.1.  Cardiac Rehabilitation Revenue Share By End User

10.2.     Rehabilitation Centers

10.3.     Hospitals and Clinics

10.4.     Homecare

10.5.     Others

CHAPTER NO. 11: CARDIAC REHABILITATION MARKET – REGIONAL ANALYSIS

11.1.     Cardiac Rehabilitation Overview by Region Segment

11.1.1.  Global Cardiac Rehabilitation Revenue Share By Region

11.1.2.  Regions

11.1.3.  Global Cardiac Rehabilitation Revenue By Region

11.1.4. Product Type

11.1.5.  Global Cardiac Rehabilitation Revenue By Product Type

11.1.6.  Indication

11.1.7. Global Cardiac Rehabilitation Revenue By Indication

11.1.8. End User

11.1.9. Global Cardiac Rehabilitation Revenue By End User

CHAPTER NO. 12: NORTH AMERICA CARDIAC REHABILITATION MARKET – COUNTRY ANALYSIS

12.1.     North America Cardiac Rehabilitation Overview by Country Segment

12.1.1.  North America Cardiac Rehabilitation Revenue Share By Region

12.2.     North America

12.2.1.  North America Cardiac Rehabilitation Revenue By Country

12.2.2.  Product Type

12.2.3.  North America Cardiac Rehabilitation Revenue By Product Type

12.2.4.  Indication

12.2.5.  North America Cardiac Rehabilitation Revenue By Indication

12.2.6.  End User

12.2.7.  North America Cardiac Rehabilitation Revenue By End User

2.3.      U.S.

12.4.     Canada

12.5.     Mexico

CHAPTER NO. 13: EUROPE CARDIAC REHABILITATION MARKET – COUNTRY ANALYSIS

13.1.     Europe Cardiac Rehabilitation Overview by Country Segment

13.1.1.  Europe Cardiac Rehabilitation Revenue Share By Region

13.2.     Europe

13.2.1.  Europe Cardiac Rehabilitation Revenue By Country

13.2.2.  Product Type

13.2.3.  Europe Cardiac Rehabilitation Revenue By Product Type

13.2.4.  Indication

13.2.5.  Europe Cardiac Rehabilitation Revenue By Indication

13.2.6.  End User

13.2.7.  Europe Cardiac Rehabilitation Revenue By End User

13.3.     UK

13.4.     France

13.5.     Germany

13.6.     Italy

13.7.     Spain

13.8.     Russia

13.9.   Rest of Europe

CHAPTER NO. 14: ASIA PACIFIC CARDIAC REHABILITATION MARKET – COUNTRY ANALYSIS

14.1.     Asia Pacific Cardiac Rehabilitation Overview by Country Segment

14.1.1.  Asia Pacific Cardiac Rehabilitation Revenue Share By Region

14.2.     Asia Pacific

14.2.1.  Asia Pacific Cardiac Rehabilitation Revenue By Country

14.2.2.  Product Type

14.2.3.  Asia Pacific Cardiac Rehabilitation Revenue By Product Type

14.2.4.  Indication

14.2.5.  Asia Pacific Cardiac Rehabilitation Revenue By Indication

14.2.5.  End User

14.2.7.  Asia Pacific Cardiac Rehabilitation Revenue By End User

14.3.     China

14.4.     Japan

14.5.     South Korea

14.6.     India

14.7.     Australia

14.8.     Southeast Asia

14.9.     Rest of Asia Pacific

CHAPTER NO. 15: LATIN AMERICA CARDIAC REHABILITATION MARKET – COUNTRY ANALYSIS

15.1.     Latin America Cardiac Rehabilitation Overview by Country Segment

15.1.1.  Latin America Cardiac Rehabilitation Revenue Share By Region

15.2.     Latin America

15.2.1.  Latin America Cardiac Rehabilitation Revenue By Country

15.2.2.  Product Type

15.2.3.  Latin America Cardiac Rehabilitation Revenue By Product Type

15.2.4.  Indication

15.2.5.  Latin America Cardiac Rehabilitation Revenue By Indication

15.2.6.  End User

15.2.7.  Latin America Cardiac Rehabilitation Revenue By End User

15.3.     Brazil

15.4.     Argentina

15.5.     Rest of Latin America

CHAPTER NO. 16: MIDDLE EAST CARDIAC REHABILITATION MARKET – COUNTRY ANALYSIS

16.1.     Middle East Cardiac Rehabilitation Overview by Country Segment

16.1.1.  Middle East Cardiac Rehabilitation Revenue Share By Region

16.2.     Middle East

16.2.1.  Middle East Cardiac Rehabilitation Revenue By Country

16.2.2.  Product Type

16.2.3.  Middle East Cardiac Rehabilitation Revenue By Product Type

16.2.4.  Indication

16.2.5.  Middle East Cardiac Rehabilitation Revenue By Indication

16.2.6.  End User

16.2.7.  Middle East Cardiac Rehabilitation Revenue By End User

16.3.     GCC Countries

16.4.     Israel

16.5.     Turkey

16.6.     Rest of Middle East

CHAPTER NO. 17: AFRICA CARDIAC REHABILITATION MARKET – COUNTRY ANALYSIS

17.1.     Africa Cardiac Rehabilitation Overview by Country Segment

17.1.1.  Africa Cardiac Rehabilitation Revenue Share By Region

17.2.     Africa

17.2.1.  Africa Cardiac Rehabilitation Revenue By Country

17.2.2.  Product Type

17.2.3.  Africa Cardiac Rehabilitation Revenue By Product Type

17.2.4.  Indication

17.2.5.  Africa Cardiac Rehabilitation Revenue By Indication

17.2.6.  End User

17.2.7.  Africa Cardiac Rehabilitation Revenue By End User

17.3.     South Africa

17.4.     Egypt

17.5.     Rest of Africa

CHAPTER NO. 18: COMPANY PROFILES 

18.1.     Philips Healthcare

18.1.1.  Company Overview

18.1.2.  Product Portfolio

18.1.3.  Financial Overview

18.1.4.  Recent Developments

18.1.5.  Growth Strategy

18.1.6.  SWOT Analysis

18.2.     Medtronic, PLC

18.3.     GE Healthcare

18.4.     Cardiac Science Corporation

18.5.     LivaNova PLC

18.6.     Baxter International Inc.

18.7.     Fujifilm Holdings Corporation

18.8.     BioTelemetry, Inc.

18.9.     Milwaukee Instruments, Inc.

18.10.   Hill-Rom Holdings, Inc.

Request Sample

Request Free Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

cr-clients-logos

Frequently Asked Questions:

What is the current market size for Cardiac Rehabilitation, and what is its projected size in 2032?

The Cardiac Rehabilitation market was valued at USD 2,292.87 million in 2024 and is projected to reach USD 3,924.20 million by 2032, reflecting strong growth driven by the increasing global burden of cardiovascular diseases and expanding access to structured rehab programs.

Which Cardiac Rehabilitation market segment held the largest share in 2024?

In 2024, the Treadmill segment led the market by product type, due to its widespread use in cardiac rehab centers for controlled cardiovascular training and real-time patient monitoring, supported by increasing demand for smart, connected fitness equipment.

Who are the leading companies in the Cardiac Rehabilitation market?

Top players include Philips Healthcare, Medtronic PLC, GE Healthcare, LivaNova PLC, Baxter International, and BioTelemetry, Inc., all of which offer advanced monitoring systems, digital health solutions, and rehabilitation equipment through strategic collaborations and innovation.

Which region commanded the largest share of the Cardiac Rehabilitation market in 2024?

North America dominated the global market in 2024 with a 42.3% share (valued at USD 969.69 million), driven by high healthcare expenditure, early adoption of advanced technologies, favorable insurance policies, and the growing prevalence of cardiovascular diseases.

About Author

Shweta Bisht

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports By Keyword

Intracardiac Imaging Market

The Intracardiac Imaging Market size was valued at USD 746.8 million in 2024 and is anticipated to reach USD 1,154.2 million by 2032, at a CAGR of 5.6% during the forecast period.

Cardiac Assist Devices Market

The  Cardiac Assist Devices Market is projected to grow from USD 1737 million in 2024 to an estimated USD 3360.7 million by 2032, with a compound annual growth rate (CAGR) of 8.6% from 2024 to 2032.

Cardiac Monitoring Devices Market

The Cardiac Monitoring Devices Market size was valued at USD 17,868.9 million in 2018 to USD 24,319.0 million in 2024 and is anticipated to reach USD 36,541.2 million by 2032, at a CAGR of 5.23% during the forecast period.

Temporary Cardiac Pacing Wires Market

The Temporary Cardiac Pacing Wires Market was valued at USD 307.12 million in 2018 and reached USD 458.30 million in 2024. It is anticipated to reach USD 776.31 million by 2032, reflecting a compound annual growth rate (CAGR) of 6.34% during the forecast period.

Cardiac Surgery and Heart Valve Devices Market

Cardiac Surgery And Heart Valve Devices Market size was valued at USD 10758.56 million in 2024 and is anticipated to reach USD 24793.51 million by 2032, at a CAGR of 11% during the forecast period (2024-2032).

Cardiac Rhythm Management Devices Market

The Cardiac Rhythm Management Devices Market size was valued at USD 24720 million in 2024 and is anticipated to reach USD 34619.67 million by 2032, at a CAGR of 4.3% during the forecast period (2024-2032).

Cardiac Ultrasound Systems Market

The global Cardiac Ultrasound Systems Market is projected to grow from USD 1,444.5 million in 2024 to USD 2,794.83 million by 2032, registering a compound annual growth rate (CAGR) of 8.6% during the forecast period.

Cardiac Ambulatory Monitoring Market

The global Cardiac Ambulatory Monitoring Market size is projected to grow from USD 5,915 million in 2024 to USD 9,146.73 million by 2032, at a compound annual growth rate (CAGR) of 5.6%.

Intracardiac Echocardiography Market

The Intracardiac Echocardiography Market is projected to grow from USD 713.9 million in 2024 to an estimated USD 1163.86 million by 2032, with a compound annual growth rate (CAGR) of 6.3% from 2024 to 2032.

Related Reports

Urology Devices Market

The Urology Devices Market size was valued at USD 26,300.0 million in 2018 to USD 34,059.0 million in 2024 and is anticipated to reach USD 60,058.8 million by 2032, at a CAGR of 7.4% during the forecast period.

Urology Imaging Systems Market

The Urology Imaging Systems Market size was valued at USD 380.0 million in 2018 to USD 427.9 million in 2024 and is anticipated to reach USD 585.2 million by 2032, at a CAGR of 4.0% during the forecast period.

Epigenetics Diagnostics Market

The epigenetics diagnostics market size was valued at USD 19302 million in 2024 and is anticipated to reach USD 62412.4 million by 2032, at a CAGR of 15.8 % during the forecast period (2024-2032).

Handheld Echocardiography Devices Market

The Handheld Echocardiography Devices Market was valued at USD 3,251.1 million in 2024 and is projected to reach USD 4,623.4 million by 2032, reflecting a CAGR of 4.5% during the forecast period.

Endoscope Reprocessing Market

The Endoscope Reprocessing Market was valued at USD 3,190.5 million in 2024 and is projected to reach USD 6,357.2 million by 2032, registering a CAGR of 9% during the forecast period.

Concentrator Devices Market

The Global Concentrator Devices Market size was valued at USD 1,426.83 million in 2018 to USD 2,414.14 million in 2024 and is anticipated to reach USD 5,018.71 million by 2032, at a CAGR of 8.92% during the forecast period.

Stent Retriever Market

Stent Retriever Market size was valued at USD 2605.4 million in 2024 and is anticipated to reach USD 5424.5 million by 2032, at a CAGR of 9.6% during the forecast period.

ENT Workstation Market

The ent workstation market  size was valued at USD 63774.9 million in 2024 and is anticipated to reach USD 112897.4 million by 2032, at a CAGR of 7.4 % during the forecast period (2024-2032).

Endovascular Treatment Devices Market

Endovascular Treatment Devices Market size was USD 3,480.5 million in 2024 and is projected to reach USD 7,037.5 million by 2032, registering a CAGR of 9.2% during the forecast period.

Endoscopic Stricture Management Device Market

Endoscopic Stricture Management Device Market size was valued at USD 1490.5 million in 2024 and is anticipated to reach USD 2357.7 million by 2032, at a CAGR of 5.9% during the forecast period.

Endometriosis Treatment Market

The Endometriosis Treatment Market size was valued at USD 1640.5 million in 2024 and is anticipated to reach USD 4061.8 million by 2032, growing at a CAGR of 12% during the forecast period.

Endomyocardial Biopsy Market

Endomyocardial Biopsy Market size was valued at USD 355.8 million in 2024 and is anticipated to reach USD 611.3 million by 2032, at a CAGR of 7% during the forecast period.

Purchase Options

The report comes as a view-only PDF document, optimized for individual clients. This version is recommended for personal digital use and does not allow printing. Use restricted to one purchaser only.
$4999

To meet the needs of modern corporate teams, our report comes in two formats: a printable PDF and a data-rich Excel sheet. This package is optimized for internal analysis. Unlimited users allowed within one corporate location (e.g., regional office).
$6999

The report will be delivered in printable PDF format along with the report’s data Excel sheet. This license offers 100 Free Analyst hours where the client can utilize Credence Research Inc. research team. Permitted for unlimited global use by all users within the purchasing corporation, such as all employees of a single company.
$12999

Let us help you

Credence Staff 3

WILLIAM, North America

+1 304 308 1216

Support Staff at Credence Research

KEITH PHILLIPS, Europe

+44 7809 866 263

Lee - CR Sales Staff

LEE VALLANCE, Asia Pacific

+64 22 017 0275

Kieran Jameson

KIERAN JAMESON, Australia

+61 4192 46279

Report delivery within 24 to 48 hours

What people say?

User Review

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

User Review

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

cr-clients-logos

Request Sample